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Abstract The expression of two factors involved in the nuclear^
mitochondrial crosstalk, namely the mitochondrial transcription
factor A (TFAM) and the nuclear respiratory factor-1 (NRF-1),
was studied in human skeletal muscle biopsies of young and aged
subjects. Aged subjects presented a 2.6-fold and an 11-fold
increase of the levels of TFAM protein and TFAM mRNA,
respectively. The increased expression of TFAM was associated
to the doubling of NRF-1 DNA-binding affinity and to a 6-fold
increase of NRF-1 mRNA level. The upregulation of TFAM and
NRF-1, in aged skeletal muscle, appears involved in the pathway
leading to the age-related increase of mitochondrial DNA
content. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Aging is a very complex phenomenon involving several
changes both at cellular and at organism levels [1,2]. Recently,
we studied phenotypic and genotypic changes of mitochondria
in a large collection of skeletal muscle specimens from healthy
Italian subjects of di¡erent ages. We found that skeletal
muscle specimens from aged subjects were characterized by
the presence of cytochrome c oxidase (COX)-negative/ragged
red ¢bers (RRF), that is ¢bers lacking cytochrome c oxidase
activity and with subsarcolemmal mitochondrial proliferation
[3], and by an increased content of mitochondrial DNA
(mtDNA) [4]. This last change might be an attempt of the
cell to counteract the age-related dysfunctions of the energetic
metabolism (reviewed in [1,5^7]). The increase of mtDNA
content should be pursued through the action of the nu-
cleus-encoded regulatory factors involved in the nuclear^mi-
tochondrial crosstalk. Among such factors a relevant role is
exerted by mitochondrial transcription factor A (TFAM) and
nuclear respiratory factor-1 (NRF-1). TFAM is a mtDNA-
binding protein, essential for maintenance, replication and
transcription of mtDNA [8], whose expression is under the
control of trans-acting factors such as NRF-1, NRF-2 and
Sp1, with NRF-1 being, apparently, the major determinant
[9]. NRF-1 controls not only TFAM expression but also
that of many other nuclear genes involved in mitochondrial
biogenesis and respiratory function: mtDNA instability and
embryonic lethality were reported in the NRF-1 knockout
mouse [10]. NRF-1 should, therefore, play an important
role in coordinating the expression of nuclear and mitochon-
drial genomes in order to balance the cell energy demands and
supplies [11].
Expression of TFAM was reported to be altered in skeletal
muscle specimens from patients with mtDNA depletion
[12,13] as well as in chemically mtDNA-depleted cells
[12,14]. An increased DNA-binding activity of NRF-1 togeth-
er with an increase of its mRNA level as well as mitochondrial
biogenesis were associated to doubled oxygen consump-
tion due to the induced expression of uncoupling protein
(UCP)-1 in HeLa cells [15].
To evaluate the involvement of TFAM and NRF-1 in
aging, we analyzed the expression of these two factors in
the skeletal muscle biopsies from a group of young and
aged subjects, already characterized for COX-negative/RRF
and mtDNA content [4]. The data here reported show that
the expression of both TFAM and NRF-1 increases in aged
subjects with respect to young ones, supporting their role in
the mitochondrial compensatory response to age-related ener-
getic metabolism dysfunctions.
2. Materials and methods
2.1. Muscle samples
Skeletal muscle biopsies (200^400 mg) from Vastus lateralis were
obtained with informed consent from four young (ages 21^33 years)
and seven aged (ages 71^88 years) healthy Italian subjects, with an
ordinary physical activity, undergoing routine orthopedic surgery in
the opposite leg. All subjects had a normal medical history and no
clinical evidence of mitochondrial pathology. The protocol of this
study was approved by the Ethical Committee of the ‘G. D’Annunzio’
University of Chieti. Muscle specimens were immediately frozen in
isopentane cooled by liquid nitrogen and stored in liquid nitrogen
until analysis.
2.2. Western blotting
Rabbit anti-human TFAM antiserum was a kind gift of Dr. R.
Wiesner (Institute of Physiology, University of Koln, Germany).
Goat anti-human K-actin antiserum was purchased from Santa Cruz
Biotechnology. Total proteins were extracted with Trizol reagent
(Gibco BRL-Life Technologies) and quantitated using the Bradford
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method (Bio-Rad) according to the supplier’s instructions. 5 Wg of
total proteins were separated in 12% sodium dodecyl sulfate (SDS)^
polyacrylamide slab minigels and electroblotted onto PVDF mem-
brane (Amersham-Pharmacia). The membrane was subjected to incu-
bation with primary antiserum, washings, incubation with secondary
antibodies and ¢nal washings according to Frigeri et al. [16]. Second-
ary antibodies were labeled with horseradish peroxidase and detection
(ECL-Plus, Amersham-Pharmacia) was performed according to the
supplier’s instructions. Antibodies were used at the following dilu-
tions: the anti-TFAM primary antibody (1:5000), the anti-rabbit sec-
ondary antibody (1:2500), the anti-actin primary antibody (1:1000),
the anti-goat secondary antibody (1:2500). Autoradiographs were an-
alyzed by laser densitometry with the Ultrascan XL LKB (Pharmacia
LKB Biotechnology) equipped with the GEL-SCAN XL evaluation
software. Preliminary titration experiments allowed to establish the
protein extracts range (2.5^25 Wg) which gave a linear response of
the signal. Di¡erent exposures of each Western blot, in the time range
between 30 s and 2 min, were taken in order to ensure the linearity of
the response for both assayed proteins.
2.3. Electrophoretic mobility shift assay (EMSA)
The nuclear protein extracts were prepared by using the method of
Blough et al. [17], with an average yield of 1^2 Wg of protein/mg of
muscle tissue. The protein yield was similar for all assayed samples
indicating no age e¡ect on this parameter. Electrophoretic mobility
shift assays were carried out in a 20 Wl reaction mixture containing 50
Wg nuclear protein extract, 20 mM HEPES pH 7.9, 5 mM MgCl2, 75
mM KCl, 0.1 mM EDTA, 1 mM DTT [18], 2 Wg of sonicated salmon
sperm DNA, 2 Wg BSA and 100 fmol of a labeled probe containing a
functional NRF-1-binding site from the N-aminolevulinate synthase
promoter [15]. Preliminary titration experiments allowed to establish
the range of nuclear protein extracts (20^70 Wg) giving a linear re-
sponse of the signal. Competition experiments were carried out with
100 fmol of a probe containing a mutated NRF-1-binding site [15] to
verify the binding speci¢city. Recombinant NRF-1 was obtained from
a full-length NRF-1 cDNA clone in pGEM-7Zf(+) vector, kindly
provided by Dr. R. Scarpulla (Northwestern University Medical
School, Chicago, IL, USA).
2.4. Detection and quantitative determination of mRNAs by RT-PCR
Total RNA was isolated with Trizol reagent (Gibco BRL-Life
Technologies) according to the supplier’s instructions. The used prim-
ers for reversed transcription-polymerase chain reaction (RT-PCR)
were: GD67A (forward 837^856) and GDMID9B (reverse 1409^
1390) from [12] for glucocerebrosidase (Glace) mRNA, NRF-876F
(forward 876^895) and NRF-1138R (reverse 1138^1119) from [19]
for NRF-1 mRNA and TFA-563F (forward 563^586) and TFA-
726R (reverse 726^705) for TFAM mRNA. In all assays 0.2 WM
gene-speci¢c primers, 200 WM dNTP, 1.2 mM magnesium sulfate
and titan one tube RT-PCR system (Roche Molecular Biochemicals)
were added, according to the supplier’s instructions, to 150^750 ng of
total RNA. A standard RT-PCR pro¢le included: the RT phase of
30 min at 55‡C and 2 min at 94‡C and the PCR phase of 1 min at
94‡C, 1 min at the annealing temperature of the primers couple (57‡C
for NRF-1, 59‡C for TFAM and 60‡C for Glace) and 1 min at 68‡C
for a number of cycles ranging from 20 to 40 depending on the
template mRNA species. Dideoxy sequencing was preliminary per-
formed on the cDNA products derived from the RT-PCR reactions.
For quantitative RT-PCR the reaction mixture contained: 20 WM
dNTP and 20 WCi [K-32P]dATP (3000 Ci/mmol, NEN Life Science
Products). Aliquots of 5 Wl were taken from the mixture at determined
cycle numbers and run on 5% polyacrylamide slab minigels. The spe-
ci¢c radiolabeled bands, identi¢ed by autoradiography, were excised
from the gel, dried at 80‡C for 4 h in scintillation vials and counted in
Maxi£uor (Mallinckrodt Baker B.V.). The incorporated radioactivity
was transformed in concentration (moles/Wl) and plotted versus the
number of cycles in a semilogarithmic graph. The extrapolation to
0 cycle of the experimental line allowed the determination of the
initial concentration of the template mRNA species without need
of an external or internal standard for comparisons, according to
Garstka et al. [20].
2.5. Statistics
Results in young and aged subjects were compared using Student’s
t-test for unpaired data; P values of less than 0.05 were considered
statistically signi¢cant.
3. Results
In this study skeletal muscle specimens from young and
aged healthy subjects, already characterized for COX-nega-
tive/RRF and mtDNA content [4], were analyzed for the ex-
pression of TFAM and NRF-1. The here examined aged sub-
jects, with respect to the young ones, presented COX-negative/
RRF and an average 2.5-fold higher mtDNA content.
The level of TFAM in skeletal muscle biopsies was deter-
mined by immunoblotting experiments with a human TFAM
antiserum. The TFAM content of each aged subject was high-
er than that of all young counterparts (Fig. 1). By pooling the
samples in two groups, one including the four young individ-
uals and the other the seven aged ones, the mean value þ S.D.
in the aged group was 2.5 þ 0.5; the counterpart in the young
subjects group was 0.94 þ 0.3. A statistically signi¢cant
(P = 0.00052) 2.6-fold increase of the TFAM protein level
was found.
In the same skeletal muscle specimens, except those of the
29-year-old and the 75-year-old subjects not anymore avail-
able, the level of TFAM mRNA was determined by a kinetic
RT-PCR method. The assay is exempli¢ed in Fig. 2A, which
shows a representative autoradiography of a gel for the 164
bp RT-PCR product of TFAM mRNA, and in Fig. 2B, that
reports the derived semilogarithmic plot. In order to compare
di¡erent subjects, each value was normalized with respect to
the sample-speci¢c concentration of the constitutive transcript
of the glucocerebrosidase (Glace) gene [12], whose concentra-
tion was determined with the same method (data not shown).
Fig. 2C shows that the ratio between TFAM and Glace
mRNAs was higher in the aged subjects compared to the
young ones. By pooling together the values according to sub-
ject ages as above, the mean value þ S.D. in the young subjects
group was 8.2 þ 3.9; the counterpart in the aged group was
91.6 þ 48.8. A statistically signi¢cant (P = 0.00015) 11-fold in-
crease of the TFAM mRNA level was found in aging.
Since a reliable estimate of the NRF-1 level by Western
Fig. 1. Age-related increase of TFAM protein level in human skele-
tal muscle. 5 Wg of total protein extract for each sample was sub-
jected to Western blotting. A: Representative experiment with all
assayed samples. Numbers on top of lanes indicate ages of subjects.
B: Ratio between the densitometric quantitations of TFAM and
K-actin in each specimen. All values are referred to that of the
33-year-old subject set equal to 1 and represent the mean þ S.D. of
three independent experiments.
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blotting was not obtainable because of the low amount of the
protein [15], NRF-1 DNA-binding activity was evaluated:
electrophoretic mobility shift assay (EMSA) of nuclear pro-
teins extracted from the eight, still available, skeletal muscle
samples was performed. By using a probe containing a func-
tional NRF-1-binding site [15] a retarded band was visible, as
shown in a representative gel shift experiment (Fig. 3A, lane
2). The band was abolished by substituting the functional
probe with one containing a mutated NRF-1-binding site
(Fig. 3A, lane 3) and was markedly decreased by adding a
100-fold molar excess of the unlabeled functional probe (Fig.
3A, lane 4). A NRF-1-speci¢c retarded band, having the same
mobility as that obtained with the recombinant NRF-1 (Fig.
3B, lane C), was evident in all assayed skeletal muscle speci-
mens (Fig. 3B). Quantitation of the band shift data shows that
in each aged subject the binding a⁄nity of NRF-1 was higher
than that in all young counterparts (Fig. 3C). By pooling
together the results according to subject ages as above, in
the aged subjects group the mean value þ S.D. was 2.5 þ 0.2;
that in the young one was 1.2 þ 0.1. A statistically signi¢cant
(P = 0.00006) doubling of the NRF-1-binding capacity was
veri¢ed.
Finally, we measured by RT-PCR the level of NRF-1
mRNA in the same nine samples assayed for TFAM
mRNA level. Fig. 4A reports a representative kinetics experi-
ment showing the cycle-dependent increase of the 262 bp
product of NRF-1 mRNA, whereas the corresponding semi-
logarithmic plot is shown in Fig. 4B. After normalizing each
value with respect to Glace mRNA it appears that NRF-1
mRNA level was higher in all aged subjects than in each
young subject (Fig. 4C). By pooling together the values, the
mean value þ S.D. in the young subjects group was 2.2 þ 1.6;
the counterpart in the aged group was 13.7 þ 2.1. A statisti-
cally signi¢cant (P = 0.00008) 6-fold increase of the NRF-1
mRNA level in the aged individuals versus the young counter-
parts was found.
Fig. 2. Age-related increase of TFAM mRNA level in human skele-
tal muscle. Quantitative RT-PCR of total RNA with speci¢c prim-
ers for TFAM. A: Representative experiment with the 78-year-old
subject mRNA. Numbers on top of lanes indicate the cycles num-
ber. M (bp size marker) is [K-32P]-labeled pBR322UHinfI. B: Semi-
logarithmic plot of the signals shown in A. C: Ratio between the
concentrations of TFAM mRNA and Glace mRNA in all assayed
subjects. Values represent the mean þ S.D. of three independent ex-
periments.
Fig. 3. Age-related increase of NRF-1-binding activity in human
skeletal muscle. 50 Wg of nuclear protein extract for each sample
was subjected to EMSA with di¡erent probes. A: Representative
competition experiments with the 78-year-old subject nuclear extract.
The position of the NRF-1-speci¢c gel shift is indicated by the ar-
row. From left to right are shown: the probe containing a function-
al NRF-1-binding site without added protein (lane 1), the same
functional probe with added nuclear protein (lane 2), the probe
with a mutated NRF-1-binding site with the added protein (lane 3),
the functional probe diluted by a 100-fold molar excess of the same
unlabeled probe with the added protein (lane 4). B: Representative
experiment with all assayed samples. Numbers on top of lanes indi-
cate ages of subjects. Lane P contains probe only, lane C contains
the reaction with human recombinant NRF-1. The intense radioac-
tive band at the bottom of the gel is free probe about to run o¡.
C: Densitometric quantitation of NRF-1 gel shifts for each speci-
men. All values have been referred to that of the 33-year-old subject
set equal to 1 and represent the mean þ S.D. of three independent
experiments.
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4. Discussion
This is the ¢rst report about the expression of two trans-
acting factors deeply involved in the regulation of mitochon-
drial biogenesis in a physiological situation as aging. The re-
sults here reported demonstrate an increased expression of
TFAM and NRF-1 in the same aged skeletal muscle samples
where COX-negative/RRF and an increased mtDNA copy
number were found. The 2.6-fold increase of the TFAM
amount in aged subjects with respect to young ones closely
corresponds to the average increase of the mtDNA content in
the same specimens (2.5-fold); this suggests that the ratio
between mtDNA and TFAM levels is maintained constant
in skeletal muscle during aging. Such a close relationship be-
tween TFAM and mtDNA was already demonstrated in the
TFAM knockout mouse [8] and in pathologies with mtDNA
depletion [12,13]. The increase with age of TFAM expression
seems to be transcriptionally regulated because of the in-
creased TFAM mRNA level. However, the di¡erence in the
magnitude of mRNA and protein increases suggests that the
amount of TFAM during aging might be regulated also by a
post-transcriptional mechanism as changes in translation rate
or in protein turnover. The upregulation of the TFAM gene
appears to be dependent on an increased activity of NRF-1,
as suggested by its increased DNA-binding a⁄nity in aged
subjects. Such an increase might be due to changes in the
phosphorylation state of this factor with age. A phosphoryla-
tion of speci¢c serine residues within the DNA-binding do-
main of NRF-1 has been, in fact, reported, resulting in a
marked stimulation of the protein-binding activity [21]. How-
ever, the simultaneous increase with age of NRF-1 mRNA
level suggests that the raised NRF-1-binding activity might
also depend on an increased amount of the corresponding
protein. The level of NRF-1 mRNA is lower than that of
TFAM mRNA both in young and in aged subjects. This is
what should be expected, being NRF-1 positioned upwards to
TFAM in the cascade of regulatory steps leading to mito-
chondrial proliferation [9,11].
The data here reported raise the question about the signals
triggering, in skeletal muscle of aged subjects, the upregula-
tion of NRF-1 and of TFAM and, consequently, the increase
of mtDNA copy number and, eventually, the mitochondrial
proliferation in COX-negative/RRF. A large number of evi-
dences link the production of ROS with aging [1,5^7]. Various
stress responsive genes, including oxidative stress-inducible
genes, have been reported to be induced in aging mouse skel-
etal muscle [22]. It is possible that, similarly to what occurs
with other ROS-sensitive transcription factors as NF-UB,
HSF and YAP1 [23], ROS themselves, mainly as H2O2, might
be the molecular message that, escaping from defective mito-
chondria, reaches the nucleus activating mitochondrial bio-
genesis [24,25]. In addition to this, as already suggested, mi-
tochondrial uncoupling, that might occur as a preliminary
response of mitochondria to an increased ROS level [26], by
raising the intracellular calcium level, might activate calcium-
regulated kinases that could phosphorylate NRF-1 and induce
the mtDNA content increase and, eventually, mitochondrial
proliferation [15].
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